Overview
- Editors:
-
-
Linda M. Pullan
-
Department of Pharmacology, Zeneca Pharmaceuticals Group, Wilmington, USA
-
Jitendra Patel
-
Department of Pharmacology, Zeneca Pharmaceuticals Group, Wilmington, USA
Access this book
Other ways to access
Table of contents (10 chapters)
-
-
-
- Husseini K. Manji, William Z. Potter
Pages 35-83
-
- Helen C. Jackson, David J. Nutt
Pages 85-131
-
-
- Dennis Paul, Gavril W. Pasternak
Pages 167-192
-
-
-
- Shutish C. Patel, Kamlesh Asotra, Yogesh C. Patel
Pages 323-342
-
- Barbara Stauch Slusher, Paul F. Jackson, Lisa A. Arvanitis
Pages 343-388
-
- Robert Siman, Barry D. Greenberg
Pages 389-428
-
Back Matter
Pages 429-434
About this book
Neuroscience's inherent complexity and rapid growth mean that no one can keep abreast of all the changes across the field. We each bring a necessarily narrow perspective. Neurotherapeutics: Emerg ing Strategies is an attempt to provide some diverse perspectives within the hunt for new drugs to treat central nervous system diseases. The book's premise is that the search for new drugs is based on an understanding ofboth clinical and basic sciences. Neurotherapeu tics: Emerging Strategies begins with psychiatry and concludes with neurological disorders. Each chapter examines a disease, including clinical features and existing treatments, but the emphasis is on current concepts of underlying causes and novel strategies for drug discovery arising from these possible mechanisms. Participating authors include basic neuroscientists, industry-based pharmacolo gists and chemists, and clinicians. The chapters describe the status of the existing disease treat ments, and when treatments are lacking, the approach is more basic science oriented. When there is a long history of treatment, there is greater emphasis on those therapies. However, all the chapters seem to reflect the benefits of cloning, since the availability of receptor subtypes now promises the opportunity for greater specificity of drug effects. Modulation of second messengers is another new and recur ring theme. And in the chapter on cachexia, cytokines are explored both as drugs and drug targets. Neurotherapeutics: Emerging Strategies reflects the complex ity of the nervous system, but the overriding message is hope for new and better drugs to treat those diseases that rob us of ourselves.
Reviews
...would be of use to the clinician wanting a better understanding of current research approaches in the neurosciences or to the basic scientist wanting a quick update on areas beyond their expertise.-Journal of Medicinal Chemistry
